-+ 0.00%
-+ 0.00%
-+ 0.00%

AXSOME THERAPEUTICS SHARES GAIN 1.4% PREMARKET AFTER FDA GRANTS PRIORITY REVIEW FOR CO'S ALZHEIMER’S AGITATION DRUG

Reuters·12/31/2025 12:25:48

Please log in to view news